
("Sunrise" or the "Company")
21 May 2025
HALF-YEARLY REPORT 2025
A copy of this report is also available on the Company's website, www.sunriseresourcesplc.com.
OPERATIONAL HIGHLIGHTS
We continue working diligently to position our mine-ready
Pioche Sepiolite
Sepiolite is a rare but important speciality clay used mainly for its gelling and absorbing properties.
· Data package received from Tolsa covering the results of work undertaken since exploration began in 2022, including:
Ø Geological mapping, trenching, surface sampling, auger drilling (20 holes drilled in 2023) and sonic drilling (10 holes drilled in 2024).
Ø Testing results for samples from the above field programmes.
· Data review has been completed with the following conclusions:
Ø Extensive sepiolite beds have been discovered over an area of 2.6km x 1.3km with samples containing up to 92% sepiolite.
Ø 3-D modelling by the Company has demonstrated that the sepiolite beds are continuous across this project area at or near surface, so suitable for open pit mining with low strip ratios.
Ø Outer limits of sepiolite deposit not yet defined.
Ø Whilst drilling has demonstrated continuity of sepiolite beds, drill spacing is too wide (average c. 300m) for effective correlation of specific sepiolite grades.
Ø Sepiolite morphology (important for commercial properties) is similar to that found in the IMV sepiolite mine in the
· Extensive testing programme initiated to simulate processing methods employed for commercial sepiolite production in the US. Early results:
Ø compare very favourably with commercially available sepiolite in the US;
Ø confirm the commercial potential of
· Timing for new market entrant is favourable due to:
Ø Expectation of a strong increase in oil/gas well drilling activity under the
Ø The existential environmental threats to the
Financial Results Summary
· Group loss for the six-months ended
Ø Other income of
Ø Interest income of
Ø Expensed pre-licence exploration costs totalling
Ø Impairment adjustment (credit) of
· Project expenditure of
Funding during the period
Funds of
Shares to the value of
On
The Company relies upon periodic capital fundraisings until such time as cashflow can be derived either from the sale of assets or future operations.
Further information:
|
Tel: +44 (0)1625 838 884 |
Nominated Adviser |
Tel: +44 (0)207 628 3396 |
Broker |
Tel: +44 (0)207 469 0930 |
CAUTIONARY NOTICE
The news release may contain certain statements and expressions of belief, expectation or opinion which are forward looking statements, and which relate, inter alia, to the Company's proposed strategy, plans and objectives or to the expectations or intentions of the Company's directors. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors beyond the control of the Company that could cause the actual performance or achievements of the Company to be materially different from such forward-looking statements. Accordingly, you should not rely on any forward-looking statements and save as required by the AIM Rules for Companies or by law, the Company does not accept any obligation to disseminate any updates or revisions to such forward-looking statements.
MARKET ABUSE REGULATION (MAR) DISCLOSURE
The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 which forms part of
NOMINATED ADVISER
Chairman's Statement
I am pleased to present our unaudited interim results for the six months ended
Operational Progress
The mine-permitted
From an operational standpoint, in this reporting period, the
Together with our expert consultant,
We have also launched an extensive testing programme on Tolsa's samples from
Notably, the largest single market for sepiolite in the US is in oil and gas well drilling, a segment not currently served by Tolsa. With renewed US policy emphasis on domestic energy production, we believe that the
The only producing sepiolite deposit in the US, located in the
Other Projects
The Company also holds a portfolio of non-core industrial mineral, gold, silver and base metals projects. All are drill ready and are owned 100% by the Company without underlying royalties or other encumbrances.
These projects have come back into focus recently due to changes in market conditions. The US dollar gold price has reached record highs, driven by persistent economic uncertainty, central bank buying, inflation concerns and geopolitical instability - including conflicts in the
Against this backdrop, we have an active programme to valorise non-core assets and hope to report progress in due course.
Corporate Developments
In
We recognise the importance of effective communication with shareholders. To that end we have engaged
Looking Ahead
Our focus remains firmly on progressing our key projects towards commercial production. We are committed to our strategic objective of delivering long-term value for shareholders through project development, sales of non-core assets and retained royalty interests.
On behalf of the Board, I extend our sincere gratitude to our shareholders for their continued support and confidence in
Sincerely,
Executive Chairman
Consolidated Income Statement
for the six months to
|
Six months to 31 March 2025 Unaudited |
Six months to 31 March 2024 Unaudited
|
Twelve months to 30 September 2024 Audited |
|
£ |
£ |
£ |
Revenue |
- |
59,438 |
112,050 |
Cost of sales |
- |
- |
(41,146) |
Gross profit |
- |
59,438 |
70,904 |
|
|
|
|
Other income |
1,968 |
83,212 |
78,435 |
Pre-licence exploration costs |
(1,443) |
(678) |
304 |
Reversal of impairment of deferred exploration assets |
(3,663) |
1,226 |
(422,135) |
Administration costs |
(144,781) |
(209,723) |
(386,766) |
Operating loss |
(147,919) |
(66,525) |
(659,258) |
|
|
|
|
Interest receivable |
17 |
412 |
452 |
|
|
|
|
Loss before income tax |
(147,902) |
(66,113) |
(658,806) |
|
|
|
|
Income tax |
- |
- |
- |
|
|
|
|
Loss for the period attributable to equity |
|
|
|
holders of the parent |
(147,902) |
(66,113) |
(658,806) |
|
|
|
|
|
|
|
|
Loss per share - basic and fully diluted (pence) (Note 2) |
(0.003) |
(0.002) |
(0.015) |
Consolidated Statement of Comprehensive Income
for the six months to
|
Six months to 31 March 2025 Unaudited |
Six months to 31 March 2024 Unaudited
|
Twelve months to 30 September 2024 Audited |
|
£ |
£ |
£ |
|
|
|
|
Loss for the period |
(147,902) |
(66,113) |
(658,806) |
|
|
|
|
Other comprehensive income: |
|
|
|
|
|
|
|
Items that could be reclassified subsequently to the Income Statement: |
|
|
|
|
|
|
|
Foreign exchange translation differences on |
|
|
|
foreign currency net investments in subsidiaries |
62,808 |
(72,021) |
(201,584) |
|
|
|
|
Items that will not be reclassified to the Income Statement: |
|
|
|
|
|
|
|
Changes in the fair value of equity investments |
(2,095) |
7,288 |
(1,954) |
|
|
|
|
|
60,713 |
(64,733) |
(203,538) |
|
|
|
|
Total comprehensive loss for the period |
|
|
|
attributable to equity holders of the parent |
(87,189) |
(130,846) |
(862,344) |
Consolidated Statement of Financial Position
as at
|
As at 31 March 2025 Unaudited |
|
As at 31 March 2024 Unaudited
|
|
As at 30 September 2024 Audited |
|
£ |
|
£ |
|
£ |
|
|
|
|
|
|
Non-current assets |
|
|
|
|
|
Intangible assets |
1,905,562 |
|
2,359,576 |
|
1,832,826 |
Other investments |
6,329 |
|
17,992 |
|
7,930 |
|
1,911,891 |
|
2,377,568 |
|
1,840,756 |
|
|
|
|
|
|
Current assets |
|
|
|
|
|
Receivables |
90,058 |
|
147,419 |
|
179,813 |
Cash and cash equivalents |
91,730 |
|
161,911 |
|
102,425 |
|
181,788 |
|
309,330 |
|
282,238 |
|
|
|
|
|
|
Current liabilities |
|
|
|
|
|
Trade and other payables |
(165,792) |
|
(160,068) |
|
(127,887) |
Lease liability |
- |
|
(2,557) |
|
- |
Convertible loan note |
(123,000) |
|
(275,000) |
|
(195,000) |
|
(288,792) |
|
(437,625) |
|
(322,887) |
|
|
|
|
|
|
Net current (liabilities)/assets |
(107,004) |
|
(128,295) |
|
(40,649) |
|
|
|
|
|
|
Non-current liabilities |
|
|
|
|
|
Provisions for liabilities and charges |
(25,384) |
|
(25,977) |
|
(24,485) |
|
(25,384) |
|
(25,977) |
|
(24,485) |
|
|
|
|
|
|
Net assets |
1,779,503 |
|
2,223,296 |
|
1,775,622 |
|
|
|
|
|
|
Equity |
|
|
|
|
|
Called up share capital |
55,330 |
|
42,753 |
|
49,450 |
Share premium account |
6,080,302 |
|
5,728,384 |
|
5,995,112 |
Share warrant reserve |
43,757 |
|
38,564 |
|
43,757 |
Capital redemption reserve |
4,054,102 |
|
4,054,102 |
|
4,054,102 |
Fair value reserve |
(1,375) |
|
9,962 |
|
720 |
Foreign currency reserve |
49,938 |
|
111,487 |
|
(12,870) |
Accumulated losses |
(8,502,551) |
|
(7,761,956) |
|
(8,354,649) |
|
|
|
|
|
|
Equity attributable to owners of the parent |
1,779,503 |
|
2,223,296 |
|
1,775,622 |
|
|
|
|
|
|
Consolidated Statement of Changes in Equity
|
Share capital |
Share premium account |
Capital redemption reserve |
Share warrant reserve |
Fair value reserve |
Foreign currency reserve |
Accumulated losses |
Total |
|
£ |
£ |
£ |
£ |
£ |
£ |
£ |
£ |
At |
4,095,052 |
5,680,316 |
- |
42,815 |
2,674 |
188,714 |
(7,701,048) |
2,308,523 |
Loss for the period |
- |
- |
- |
- |
- |
- |
(66,113) |
(66,113) |
Change in fair value |
- |
- |
- |
- |
7,288 |
- |
- |
7,288 |
Exchange differences |
- |
- |
- |
- |
- |
(77,227) |
- |
(77,227) |
Total comprehensive loss for |
|
|
|
|
|
|
|
|
the period |
- |
- |
- |
- |
7,288 |
(77,227) |
(66,113) |
(136,052) |
Share issue |
1,803 |
48,068 |
- |
- |
- |
- |
- |
49,871 |
Capital restructure |
(4,054,102) |
- |
- |
- |
- |
- |
- |
(4,054,102) |
Capital redemption reserve |
- |
- |
4,054,102 |
- |
- |
- |
- |
4,054,102 |
Share based payments expense |
- |
- |
- |
954 |
- |
- |
- |
954 |
Transfer of expired warrants |
- |
- |
|
(5,205) |
- |
- |
5,205 |
- |
At |
42,753 |
5,728,384 |
4,054,102 |
38,564 |
9,962 |
111,487 |
(7,761,956) |
2,223,296 |
Loss for the period |
- |
- |
- |
- |
- |
- |
(592,693) |
(592,693) |
Change in fair value |
- |
- |
- |
- |
(9,242) |
- |
- |
(9,242) |
Exchange differences |
- |
- |
- |
- |
- |
(124,357) |
- |
(124,357) |
Total comprehensive loss for |
|
|
|
|
|
|
|
|
the period |
- |
- |
- |
- |
(9,242) |
(124,357) |
(592,693) |
(726,292) |
Share issue |
6,697 |
266,728 |
- |
- |
- |
- |
- |
273,425 |
Share based payments expense |
- |
- |
- |
5,193 |
- |
- |
- |
5,193 |
At |
49,450 |
5,995,112 |
4,054,102 |
43,757 |
720 |
(12,870) |
(8,354,649) |
1,775,622 |
Loss for the period |
- |
- |
- |
- |
- |
- |
(147,902) |
(147,902) |
Change in fair value |
- |
- |
- |
- |
(2,095) |
- |
- |
(2,095) |
Exchange differences |
- |
- |
- |
- |
- |
62,808 |
- |
62,808 |
Total comprehensive loss for |
|
|
|
|
|
|
|
|
the period |
- |
- |
- |
- |
(2,095) |
62,808 |
(147,902) |
(87,189) |
Share issue (Note 3) |
5,880 |
85,190 |
- |
- |
- |
- |
- |
91,070 |
At
|
55,330 |
6,080,302 |
4,054,102 |
43,757 |
(1,375) |
49,938 |
(8,502,551) |
1,779,503 |
Consolidated Statement of Cash Flows
for the six months to
|
Six months to 31 March 2025 Unaudited |
|
Six months to 31 March 2024 Unaudited
|
|
Twelve months to 30 September 2024 Audited |
|
£ |
|
£ |
|
£ |
Operating activity
|
|
|
|
|
|
Operating loss |
(147,919) |
|
(66,525) |
|
(659,258) |
Depreciation/interest charge |
- |
|
- |
|
5,046 |
Share based payment charge |
- |
|
954 |
|
6,147 |
Deferred consideration from sale of exploration assets |
- |
|
- |
|
56,025 |
Shares issued in lieu of net wages |
19,069 |
|
12,363 |
|
12,363 |
Expenditures settled by issues of shares |
- |
|
- |
|
17,015 |
Impairment of deferred exploration asset |
- |
|
- |
|
422,135 |
Reclamation provision |
- |
|
- |
|
5,039 |
(Increase)/decrease in receivables |
89,755 |
|
(1,960) |
|
(34,355) |
Increase/(decrease) in trade and other payables |
37,905 |
|
51,295 |
|
19,115 |
Net cash outflow from operating activity |
(1,190) |
|
(3,873) |
|
(150,728) |
|
|
|
|
|
|
Investing activity |
|
|
|
|
|
|
|
|
|
|
|
Interest received |
17 |
|
412 |
|
452 |
Project development expenditures |
(5,494) |
|
(29,867) |
|
(102,580) |
Net cash outflow from investing activity |
(5,477) |
|
(29,455) |
|
(102,128) |
|
|
|
|
|
|
Financing activity |
|
|
|
|
|
|
|
|
|
|
|
Issue of share capital (net of expenses) |
- |
|
7 |
|
188,917 |
Lease payments |
- |
|
- |
|
(2,412) |
Net cash inflow from financing activity |
- |
|
7 |
|
186,505 |
|
|
|
|
|
|
Net increase/(decrease) in cash and cash equivalents |
(6,667) |
|
(33,321) |
|
(66,351) |
|
|
|
|
|
|
Cash and cash equivalents at start of period |
102,425 |
|
177,967 |
|
177,967 |
Exchange differences |
(4,028) |
|
17,265 |
|
(9,191) |
Cash and cash equivalents at end of period |
91,730 |
|
161,911 |
|
102,425 |
Notes to the Interim Statement
1. Basis of preparation
The consolidated interim financial information has been prepared in accordance with the accounting policies that are expected to be adopted in the Group's full financial statements for the year ending
The financial information in this statement relating to the six months ended
The directors prepare annual budgets and cash flow projections for a 15-month period. These projections include the proceeds of future fundraising necessary within the period to meet the Company's and the Group's planned discretionary project expenditures and to maintain the Company and the Group as a going concern. Although the Company has been successful in raising finance in the past, there is no assurance that it will obtain adequate finance in the future. These factors represent a material uncertainty related to events or conditions which may cast significant doubt on the entity's ability to continue as a going concern and, therefore, that it may be unable to realise its assets and discharge its liabilities in the normal course of business. However, the directors have a reasonable expectation that they will secure additional funding when required to continue meeting corporate overheads and exploration costs for the foreseeable future and therefore believe that the going concern basis is appropriate for the preparation of the financial statements.
2. Loss per share
Loss per share has been calculated on the attributable loss for the period and the weighted average number of shares in issue during the period.
|
Six months to 31 March 2025 Unaudited
|
Six months to 31 March 2024 Unaudited
|
Twelve months to 30 September 2024 Audited
|
|
|
|
|
Loss for the period (£) |
(147,902) |
(66,113) |
(658,806) |
|
|
|
|
Weighted average shares in issue (No.) |
5,182,977,424 |
3,962,771,483 |
4,360,320,952 |
|
|
|
|
Basic and diluted loss per share (pence) |
(0.003) |
(0.002) |
(0.015) |
The loss attributable to ordinary shareholders and weighted average number of shares for the purpose of calculating the diluted earnings per share are identical to those used for the basic earnings per share. This is because the exercise of share warrants would have the effect of reducing the loss per share and is therefore not dilutive under the terms of IAS33.
3. Share capital
During the six months to
An issue of 225,000,000 0.001p Ordinary Shares at 0.02p per share, by exercise of conversion rights in connection with the First Convertible Security held by
An issue of 270,000,000 0.001p Ordinary Shares at 0.01p per share, by exercise of conversion rights in connection with the Second Convertible Security held by
An issue of 93,021,463 0.001p Ordinary Shares at 0.0205p per share to three directors, for a total consideration of
The total number of Ordinary Shares in issue on
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the